The blow fill seal technology market is estimated to witness prolific growth during the 2018-2027 period. Growing demand for efficient packaging solution in pharmaceuticals and F&B industries is estimated to be the key factor driving the growth of the blow fill seal technology market. Blow fill seal technology’s precision and accuracy in the development in unit dosage packaging is a vital reason that is causing its widespread adoption in the pharmaceutical industry.
Blow fill seal technology is enabling pharmaceutical manufacturers in improving the flexibility of ampoules, bottles, vials, and prefilled syringes and injectables. The additional flexibility imparted to the equipment by the means of blow fill seal technology provides for convenient transportation reducing the risk of breakage.
Competitive Assessment of the Blow Fill Seal Technology Market
Some of the prominent players operating in the blow fill seal technology market include Catalent, Inc., Unipharma LLC, GlaxoSmithKline plc., Recipharm AB, Laboratorios SALVAT, S.A., Amanta Healthcare, Asept Pak, Inc., SIFI S.p.A, Brevetti Angela S.R.L, Nephron Pharmaceuticals Corporation, Weiler Engineering, Inc., Curida AS, Roomelag Kunststoff-Maschinen Vertriebsgesellschaft mbH, Horizon Pharmaceuticals, Takeda Pharmaceuticals AG, Unither Pharmaceuticals, The Ritedose Corporation, Automatic Liquid Packaging Solutions LLC, Pharmapack Co. Ltd., Unicep Packaging, LLC., NuPharm, BioConnection, Plastikon, Gerresheimer AG, and LyondellBasell Industries N.V.
For More Insights Into The Market, Request a Sample of this Report –https://www.factmr.com/connectus/sample?flag=S&rep_id=3048
Blow Fill Seal Technology Market: Promising Prospects in Healthcare Industry
Medical non-adherence is a complex healthcare problem with profound repercussions. The multidimensional problem can arise due to an assortment of reasons which can be related to the patient or the treatment and healthcare provider. In addition to risking patients’ well-being, medical non-adherence is known to cause a substantial increase in the generation of waste and cost while deterring the efficacy of treatments
A concrete example of the problem became evident after studies estimated that approximately 50% of the US population failed to consume medication as per the prescribed directions. Another survey claimed that medical non-adherence were responsible for costing the US healthcare system an additional $200 billion.
The daunting challenge that continues to pose a threat to the healthcare industry is causing pharmaceutical companies to work towards the development of advanced drug delivery systems and packaging solutions that can effectively help solve the problem. Blow seal fill technology is gradually becoming a vital part of the pharmaceutical manufacturing process owing to its ability to aid in accurate unit dosage medicine packaging.
Sustainability Offered by Blow Fill Seal Technology to Propel Widespread Adoption
In addition to providing a solution to reduce healthcare costs and improving the efficacy of treatment, blow fill seal technology’s sustainable operation augments to the popularity of the technology. Growing concerns about the environment are prompting governments around the world to impose regulations that aim towards the preservation of the environment. Consequentially, companies are looking for solutions that can aid them in improving the sustainability of their operations. Blow fill seal technology consumes less power, aid in the reduction of waste generated during manufacturing, and have a low carbon footprint. Due to these benefits, regulatory frameworks around the world are recommending the integration of blow fill seal technology in the existing production line.